Clinical Trial Update: In Situ Immune Parameters and Their Prognostic Role on the Survival of Patients With Glioblastoma

View source ↗

Summary

This completed clinical trial update assesses in situ immune parameters and their prognostic role in the survival of patients with glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Centre Georges Francois Leclerc | Conditions: Glioblastoma | Status: COMPLETED